Javascript must be enabled to continue!
Blastogenic Factor from Unstimulated Leukocyte Cultures: Further Evidence for Heterogeneity, and Mechanism of Production
View through CrossRef
Abstract
Blastogenic factor derived from unstimulated leukocyte cultures was studied. The present studies have shown that the properties of the blastogenic factor which stimulates only allogeneic cells (allogeneic blastogenic factor) are different in some respects from those of the blastogenic factor which stimulated autologous cells as much as allogeneic cells (autologous blastogenic factor). Activity of the allogeneic blastogenic factor was labile to exposure to temperature of 60°C, and was concentrated in the precipitate obtained by ultracentrifugation of cell-free culture medium (CFM) at 100,000 × G. In contrast, activity of the autologous blastogenic factor was resistant to the same temperature, and could not be sedimented by ultracentrifugation. The kinetics of in vitro production of the allogeneic blastogenic factor was also different from those of the autologous blastogenic factor. While activity of the autologous blastogenic factor was almost constant throughout the incubation period, that of the allogeneic blastogenic factor reached a maximum after 4 to 5 days of incubation and thereafter decreased. These findings suggest that there may be separate molecules responsible for the allogeneic and autologous blastogenic activities.
The blastogenic factor prepared from mixed cultures of intact cells and treated allogeneic cells was also studied. Although the difference was not significant (p = 0.09) when leukocytes were treated with actinomycin D, the CFM was more active for cells from the donor of the treated cells than for cells from the donor of the intact cells in eight out of 12 experiments. The ultracentrifuged precipitate (probably allogeneic blastogenic factor) was significantly more stimulatory toward cells from the donor of the treated cells than from the donor of the intact cells. When leukocytes were treated with Escherichia coli endotoxin, both the CFM and the ultracentrifuged precipitate stimulated cells from the donor of the treated cells more than cells from the donor of the intact cells. Mytomycin C did not have any effect on the blastogenic activity of the CFM and the ultracentrifuged precipitate prepared from these cultures.
Title: Blastogenic Factor from Unstimulated Leukocyte Cultures: Further Evidence for Heterogeneity, and Mechanism of Production
Description:
Abstract
Blastogenic factor derived from unstimulated leukocyte cultures was studied.
The present studies have shown that the properties of the blastogenic factor which stimulates only allogeneic cells (allogeneic blastogenic factor) are different in some respects from those of the blastogenic factor which stimulated autologous cells as much as allogeneic cells (autologous blastogenic factor).
Activity of the allogeneic blastogenic factor was labile to exposure to temperature of 60°C, and was concentrated in the precipitate obtained by ultracentrifugation of cell-free culture medium (CFM) at 100,000 × G.
In contrast, activity of the autologous blastogenic factor was resistant to the same temperature, and could not be sedimented by ultracentrifugation.
The kinetics of in vitro production of the allogeneic blastogenic factor was also different from those of the autologous blastogenic factor.
While activity of the autologous blastogenic factor was almost constant throughout the incubation period, that of the allogeneic blastogenic factor reached a maximum after 4 to 5 days of incubation and thereafter decreased.
These findings suggest that there may be separate molecules responsible for the allogeneic and autologous blastogenic activities.
The blastogenic factor prepared from mixed cultures of intact cells and treated allogeneic cells was also studied.
Although the difference was not significant (p = 0.
09) when leukocytes were treated with actinomycin D, the CFM was more active for cells from the donor of the treated cells than for cells from the donor of the intact cells in eight out of 12 experiments.
The ultracentrifuged precipitate (probably allogeneic blastogenic factor) was significantly more stimulatory toward cells from the donor of the treated cells than from the donor of the intact cells.
When leukocytes were treated with Escherichia coli endotoxin, both the CFM and the ultracentrifuged precipitate stimulated cells from the donor of the treated cells more than cells from the donor of the intact cells.
Mytomycin C did not have any effect on the blastogenic activity of the CFM and the ultracentrifuged precipitate prepared from these cultures.
Related Results
ANALISIS PERTIMBANGAN MAHKAMAH AGUNG DALAM MENGABULKAN KASASI TERDAKWA (STUDI PUTUSAN NOMOR 2959/K/PID.SUS/2022)
ANALISIS PERTIMBANGAN MAHKAMAH AGUNG DALAM MENGABULKAN KASASI TERDAKWA (STUDI PUTUSAN NOMOR 2959/K/PID.SUS/2022)
<p><em><span class="markedContent"><span style="left: calc(var(--scale-factor)*195.53px); top: calc(var(--scale-factor)*496.87px); font-size: calc(var(--scale-...
KEDUDUKAN AHLI BAHASA DALAM PEMBUKTIAN PERKARA PENCEMARAN NAMA BAIK (STUDI PUTUSAN NOMOR: 47/PID.SUS/2019/PN. MGT)
KEDUDUKAN AHLI BAHASA DALAM PEMBUKTIAN PERKARA PENCEMARAN NAMA BAIK (STUDI PUTUSAN NOMOR: 47/PID.SUS/2019/PN. MGT)
<em><span id="page3R_mcid52" class="markedContent"><span style="left: calc(var(--scale-factor)*125.30px); top: calc(var(--scale-factor)*539.11px); font-size: calc(va...
Genetic relations between leukocyte counts, type 1 diabetes, and coronary artery disease
Genetic relations between leukocyte counts, type 1 diabetes, and coronary artery disease
Abstract
Hypothesis/Aim
Type 1 diabetes (T1D) is associated with excess coronary artery disease (CAD) risk even when known card...
Human leukocyte antigen-G upregulates immunoglobulin-like transcripts and corrects dysfunction of immune cells in immune thrombocytopenia
Human leukocyte antigen-G upregulates immunoglobulin-like transcripts and corrects dysfunction of immune cells in immune thrombocytopenia
Human leukocyte antigen-G is a non-classical major histocompatibility complex class I antigen with potent immune-inhibitory function. Human leukocyte antigen-G benefit patients in ...
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract
Introduction
Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...
Urine dipstick test for diagnosing urinary tract infection
Urine dipstick test for diagnosing urinary tract infection
Background Urinary tract infection (UTI) is a common diseasein children. Approximately 3-5% of girls and 1 % of boys developa UTI. In children, prompt treatment is essential becaus...
Title in Chemotherapy for Acute Myeloid Leukemia with High Leukocyte Counts.
Title in Chemotherapy for Acute Myeloid Leukemia with High Leukocyte Counts.
Abstract
Introduction
Chromosomal aberration is a powerful prognostic factor for acute myeloid leukemia (AML). On the other hand, age and high leukocy...
Saliva cotinine levels as a function of collection method
Saliva cotinine levels as a function of collection method
AbstractSaliva cotinine is commonly used to estimate nicotine intake but laboratories use different methods of collection. In three small trials, comparisons were made between (1) ...

